Polaris Market Research today announced findings from its latest report, projecting the global airlift bioreactors market to grow from USD 5.14 billion in 2022 to USD 9.58 billion by 2032, at a CAGR of 6.4% from 2023 to 2032. The report profiles 10 leading companies across six market segments, offering a detailed view of market size, market share, and industry trends.

Analyst Commentary on Airlift Bioreactors Market Growth

“Market growth is being driven by the biopharmaceutical sector’s need for scalable, low-shear cell culture platforms, and industry trends such as single-use systems are making airlift technology more accessible to smaller producers,” said a Polaris Market Research analyst. “The opportunity for buyers and investors lies in vendors that can pair compact, flexible systems with a clear path from laboratory to commercial scale.”

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: The expansion of the biopharmaceutical industry is the primary force behind the market’s growth. Rising production of therapeutic proteins, antibodies, vaccines, and enzymes is increasing demand for efficient bioprocessing equipment. Strong government and funding-agency support for biotechnology R&D adds momentum, while the shift toward single-use systems, which lower contamination risk and shorten turnaround times, is widening adoption. Airlift designs also suit regenerative medicine, tissue engineering, microalgae cultivation, and biochemical production. India’s bio-economy, valued at more than USD 80 billion in 2022, is projected to reach USD 300 billion by 2030, highlighting the scale of policy-backed investment.

Market Challenges: The pandemic created a surge in demand for bioprocessing capacity to support vaccine and therapeutic production, yet it also delayed non-COVID-19 projects as resources were redirected. Supply chain disruption, limited facility access, economic uncertainty, and budget constraints slowed investment in several regions. As these pressures ease, the report expects renewed capital spending on scalable, flexible bioprocessing platforms across both established and emerging biotechnology hubs.

Major Companies Covered: Cellexus, Sartorius, Lonza, Electrolab Biotech, Shree Biocare, Rotech, Knik Technology, Solida Biotech, Zeta, and Kuhner Shaker.

Segments Covered: By Product (Internal Airlift Loop Bioreactor, External Airlift Loop Bioreactor), By Capacity (5L, 7L, 10L, 30L), By Material (Stainless Steel, Glass), By Usage (Single-Use/Disposable, Reusable), By End Use (Biopharmaceutical Companies, CROs/CDMOs, Research and Development Companies), and By Region.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/airlift-bioreactors-market 

Segment Insights: Internal Loop Designs and 30L Capacity Stand Out

Internal airlift loop bioreactors held the largest market share in 2022. Their efficient mixing, strong gas and nutrient mass transfer, and easy scalability across production sizes make them a preferred choice. The 30L capacity segment also performed strongly, as this intermediate scale gives researchers and process developers larger working volumes than lab-scale units while keeping optimization manageable. By end use, biopharmaceutical companies accounted for a significant share, since airlift systems maintain consistent hydrodynamic conditions during scale-up and support product purity.

Recent Developments in the Airlift Bioreactors Market

• April 2022: Cellexus launched a single-use airlift bioreactor, offering a more economical and effective technology for bioprocessing.
• March 2022: Cellexus partnered with Verder Liquids to supply acid/base pumps as standard on its CellMaker Plus and Low Flow bioreactor systems, used by researchers worldwide to grow cells for new drug and vaccine development.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America led the global market in 2022, supported by well-developed biopharmaceutical manufacturing infrastructure, continuous product launches, and heavy R&D investment. The U.S. alone accounts for roughly one-third of the world’s biopharmaceutical market. Asia Pacific is the fastest-growing region, driven by rising demand for bio-based products and the advantages airlift systems offer in mass transfer and oxygen transfer, which suit bio-based production such as biofuels.

Why It Matters for Buyers Evaluating Airlift Bioreactors Market Forecast

For stakeholders researching the airlift bioreactors market forecast, the underlying report benchmarks market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2032. It also covers the top companies shaping the competitive landscape, along with Porter’s Five Forces and PESTLE analysis. Readers can also request customization by region, country, or additional segment to match specific business needs.

More Trending Latest Reports By Polaris Market Research:

Film Dressing Market

Virtual Private Network Market

Glycols Market

Clindamycin Phosphate Injection Market

Virtual Private Network Market

Digital Transaction Management Market

Intracranial Stenosis Stents Market

Facts about Spare Parts Logistics Market

Fuel Cell Market